Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (AVANT): A phase 3 randomised controlled trial

Aimery de Gramont, Eric Van Cutsem, Hans Joachim Schmoll, Josep Tabernero, Stephen Clarke, Malcolm J. Moore, David Cunningham, Thomas H. Cartwright, J. Randolph Hecht, Fernando Rivera, Seock Ah Im, György Bodoky, Ramon Salazar, Frédérique Maindrault-Goebel, Einat Shacham-Shmueli, Emilio Bajetta, Martina Makrutzki, Aijing Shang, Thierry André, Paulo M. Hoff

Research output: Contribution to journalArticleResearchpeer-review

387 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (AVANT): A phase 3 randomised controlled trial'. Together they form a unique fingerprint.

Medicine & Life Sciences